Trial Profile
Multicenter study comparing the efficacy and safety of OROS (methylphenidate HCl), Ritalin, and placebo in children with ADHD
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2007
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors ALZA Corporation
- 19 Nov 2006 New trial record.